SAT0234 Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 9 years - Concepedia

Concepedia

Publication | Open Access

SAT0234 Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 9 years

DOI Full Paper Access

38

Citations

0

References

2018

Year

J. Wollenhaupt, Joel C. Silverfield, E. B. Lee, Ketti K. Terry, Kenneth Kwok, Sander Strengholt, Ryan DeMasi, L. Wang

Annals of the Rheumatic Diseases

No additional data available for this publication yet. Check back later!